@article{Swati Sharma_Fiza Nehvi_Nili Kumari_Alankrita Chaudhary_Kuldeep Dhanker_2020, title={EVALI: A Review of the Vaping Related Lung Injury}, volume={3}, url={https://ihrjournal.com/ihrj/article/view/327}, DOI={10.26440/IHRJ/0312.03327}, abstractNote={<p>Vaping or e-cigarettes were introduced to help people quit smoking tobacco but with every passing year, their demand has dramatically increased as compared to the traditional cigarettes. With the increase in the number of vapers, an alarming vaping related outbreak which was given an official name by the CDC: EVALI (Electronic cigarette or Vaping Product Associated Lung Injury). In the United States, until&nbsp; January 21<sup>st</sup>, 2020 2051 cases have been reported from all 50 states with 60 deaths confirmed in 27 states and the district of Columbia. Not much is known about the cause of this outbreak but the possible culprits could be THC(Tetrahydrocannabinol) containing materials or Vitamin E Acetate. In order to protect the youth and the adults from such health hazards the government took a step by putting a ban on E-cigarettes. After the US states of Michigan &amp; New York, India too, imposed a ban on the sale of such e-cigarettes. This review paper discusses about e-cigarettes and about its harmful effects that lead to EVALI in a person.</p&gt;}, number={12}, journal={International Healthcare Research Journal}, author={Swati Sharma and Fiza Nehvi and Nili Kumari and Alankrita Chaudhary and Kuldeep Dhanker}, year={2020}, month={Mar.}, pages={370-375} }